DVT Prophylaxis for TURP Procedures

Risk Assessment and Prophylaxis Recommendations

The American Urological Association recommends that TURP is generally considered a low-risk procedure for DVT with incidence rates of symptomatic VTE within 91 days of only 0.3-0.5% 1, 2
Patient risk stratification should guide prophylaxis decisions, considering both procedure-specific and patient-specific risk factors, such as age >60 years, prior VTE, active cancer, limited mobility, obesity, and hypercoagulable states 2, 4
For low-risk patients, early ambulation alone is sufficient and recommended, with no specific pharmacologic or mechanical prophylaxis needed 1, 2, 5
For moderate-risk patients, early ambulation plus one of the following options is recommended: graduated compression stockings (GCS) or intermittent pneumatic compression (IPC) devices 1, 2, 3
For high-risk patients, mechanical prophylaxis with IPC or GCS is recommended, with consideration of adding pharmacologic prophylaxis with low-dose unfractionated heparin (LDUH) or low molecular weight heparin (LMWH) 1, 2, 6

The American College of Chest Physicians recommends that limited data suggest greater blood loss and higher transfusion rates with LDUH in TURP patients, and that mechanical prophylaxis should be used instead of pharmacologic methods for patients at high risk for bleeding 1, 2, 5, 7
Prophylaxis should be continued throughout hospitalization for medical patients, and for 5-9 days post-procedure for surgical patients, with extended prophylaxis (4 weeks) considered for patients undergoing major cancer surgery 5, 6

Overuse of pharmacologic prophylaxis in low-risk TURP patients may increase bleeding risk unnecessarily, and failure to recognize patient-specific risk factors may elevate a seemingly low-risk procedure to moderate or high risk 1, 2, 3